Chemours Company (NYSE:CC) has a beta value of 1.95 and has seen 1.82 million shares traded in the last trading session. The company, currently valued at $4.13B, closed the last trade at $27.80 per share which meant it gained $0.66 on the day or 2.43% during that session. The CC stock price is -40.47% off its 52-week high price of $39.05 and 45.68% above the 52-week low of $15.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.46 million shares traded. The 3-month trading volume is 1.88 million shares.
Chemours Company (NYSE:CC) trade information
Sporting 2.43% in the green in last session, the stock has traded in the green over the last five days, when the CC stock price touched $27.80 or saw a rise of 0.5%. Year-to-date, Chemours Company shares have moved -11.86%, while the 5-day performance has seen it change 6.43%. Over the past 30 days, the shares of Chemours Company (NYSE:CC) have changed -0.07%. Short interest in the company has seen 4.71 million shares shorted with days to cover at 2.01.
Chemours Company (CC) estimates and forecasts
Figures show that Chemours Company shares have underperformed across the wider relevant industry. The company’s shares have lost -12.72% over the past 6 months, with this year growth rate of -36.27%, compared to 2.20% for the industry. Revenue growth from the last financial year stood is estimated to be -11.70%.
5 analysts offering their estimates for the company have set an average revenue estimate of $1.32 billion for the current quarter. 4 have an estimated revenue figure of $1.55 billion for the next quarter concluding in Mar 2024. Year-ago sales stood $1.34 billion and $1.46 billion respectively for this quarter and the next, and analysts expect sales will shrink by -1.60% for the current quarter and 5.90% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -1.34% over the past 5 years. Earnings growth for 2024 is a modest -35.30% while over the next 5 years, the company’s earnings are expected to increase by 7.40%.
CC Dividends
Chemours Company is expected to release its next earnings report between March 12 and March 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.00 at a share yield of 3.60%. The company’s dividend yield has gone up over the past 12 months.
Chemours Company (NYSE:CC)’s Major holders
Insiders own 0.78% of the company shares, while shares held by institutions stand at 77.54% with a share float percentage of 78.15%. Investors are also buoyed by the number of investors in a company, with Chemours Company having a total of 579 institutions that hold shares in the company. The top two institutional holders are FMR, LLC with over 18.92 million shares worth more than $697.98 million. As of Jun 29, 2023, FMR, LLC held 12.78% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 17.05 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $629.16 million and represent 11.52% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Core S&P Midcap ETF. As of Jun 29, 2023, the former fund manager holds about 3.13% shares in the company for having 4.63 million shares of worth $170.8 million while later fund manager owns 4.63 million shares of worth $129.84 million as of Sep 29, 2023, which makes it owner of about 3.13% of company’s outstanding stock.
